Integrin inhibitor, Lifitegrast, Purity ≥98%

Cat. No.: X24-08-YM305

Integrin inhibitor, Lifitegrast, Purity ≥98%

Synonym: 1025967-78-5; SAR-1118; SAR 1118; SAR1118; Lifitegrast; brand name: Xiidra.; (2S)-2-[[2-(1-Benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid

  • MDL: MFCD28502439
  • CAS Number: 1025967-78-5
  • Compound CID: 11965427
Product Size
10 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Lifitegrast, soluble in DMSO and ethanol and insoluble in water, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.
Molecular Weight
615.478
Molecular Formula
C29H24Cl2N2O7S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 98 mg/mL (159.22 mM); Water: insoluble; Ethanol: 20 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Lifitegrast is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of dry eye disease by blocking the interaction of integrin αLβ2 with its ligand, which reduces inflammation and improves symptoms.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.